Abstract P065: Proteogenomic characterization of CDK4/6 inhibitor-resistant ER+ breast cancer. Chen, C. T, Leshchiner, I., Martin, L., Kane, H., Rhrissorrakrai, K., Utro, F., Levovitz, C., Gillette, M., Satpathy, S., Pinto, C., & others Molecular Cancer Therapeutics, 20(12_Supplement):P065–P065, The American Association for Cancer Research, 2021.
bibtex   
@article{chen2021abstract,
  title={Abstract P065: Proteogenomic characterization of CDK4/6 inhibitor-resistant ER+ breast cancer},
  author={Chen, Christopher T and Leshchiner, Ignaty and Martin, Liz and Kane, Harry and Rhrissorrakrai, Kahn and Utro, Filippo and Levovitz, Chaya and Gillette, Michael and Satpathy, Shankha and Pinto, Christopher and others},
  journal={Molecular Cancer Therapeutics},
  volume={20},
  number={12\_Supplement},
  pages={P065--P065},
  year={2021},
  publisher={The American Association for Cancer Research}
}

Downloads: 0